within Pharmacolibrary.Drugs.ATC.J;

model J01CF05
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.53,
    Cl             = 0.10333333333333333,
    adminDuration  = 600,
    adminMass      = 0.5,
    adminCount     = 1,
    Vd             = 0.01,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.011583333333333333,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Flucloxacillin is a beta-lactam antibiotic of the penicillin class, primarily used to treat infections caused by susceptible Gram-positive bacteria, including staphylococcal infections. It is widely used and approved for medical use today for conditions such as skin, bone, and joint infections, as well as pneumonia and endocarditis.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult volunteers following oral administration of flucloxacillin capsules.</p><h4>References</h4><ol><li><p>Drennan, PG, et al., &amp; Chambers, ST (2021). Population pharmacokinetics of free flucloxacillin in patients treated with oral flucloxacillin plus probenecid. <i>British journal of clinical pharmacology</i> 87(12) 4681–4690. DOI:<a href=&quot;https://doi.org/10.1111/bcp.14887&quot;>10.1111/bcp.14887</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/33963595/&quot;>https://pubmed.ncbi.nlm.nih.gov/33963595</a></p></li><li><p>De Smet, S, et al., &amp; Huis In &#x27;t Veld, D (2024). Retrospective analysis of a flucloxacillin oral absorption test in patients requiring flucloxacillin therapy: results and determination of factors associated with adequate absorption. <i>Acta clinica Belgica</i> 79(3) 184–192. DOI:<a href=&quot;https://doi.org/10.1080/17843286.2024.2382981&quot;>10.1080/17843286.2024.2382981</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/39054877/&quot;>https://pubmed.ncbi.nlm.nih.gov/39054877</a></p></li><li><p>van Daele, PLA (2019). Therapeutic drug monitoring of flucloxacillin. <i>The Netherlands journal of medicine</i> 77(7) 233–None. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/31582583/&quot;>https://pubmed.ncbi.nlm.nih.gov/31582583</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end J01CF05;
